Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pharmacogenetics

View through CrossRef
Abstract Pharmacogenetics (PGt) is the study of the influence of individual variations in deoxyribonucleic acid sequence on drug response. Drug response includes drug disposition (pharmacokinetics) and drug effect (pharmacodynamics). PGt is applicable to activities such as drug discovery, drug development and clinical practise. Currently, there are more than 200 drugs whose labelling includes pharmacogenetic information. ‘Test required’ examples: Cetuximab, Trastuzumab, Maraviroc, Abacavir, Dasatinib, Glivec, Tasigna, Gefitinib and Herceptin; ‘Test recommended’ examples: Carbamazepine, warfarin, azathioprine, etc. In the coming years, evaluation by regulatory authorities of new medicines may involve increasingly PGt components in pre‐ and post‐approval development, and may therefore depend on reliable PGt information. PGt is a rapidly and continuously evolving field; therefore, PGt studies should reflect on the ‘principles’ or necessary qualities of developing well‐controlled, rigorous and reproducible sample handling and testing procedures. Key Concepts: Pharmacogenetics define populations that can have most benefit from a drug. Pharmacogenetics improve drug development. Pharmacogenetics predict disease course (to justify more intense or prolonged treatments) (diagnostics and prognostics). Pharmacogenetics can be used to monitor the effects of the therapy (pharmacodynamics). Genomic biomarkers predict clinical outcomes (surrogate endpoints). Pharmacogenetics can be useful to identify new biological pathways involved in drug metabolism and therefore new treatment opportunities. Pharmacogenetics is applicable to activities such as drug discovery, drug development and clinical practise. Pharmacogenetics is applicable also in drug disposition (PK) and drug effect (PD). Pharmacogenetics is necessary to define individual dose adaptation of chemotherapeutics and in general for personalised medicine. Pharmacogenetics is crucial in genomic biomarkers identification.
Title: Pharmacogenetics
Description:
Abstract Pharmacogenetics (PGt) is the study of the influence of individual variations in deoxyribonucleic acid sequence on drug response.
Drug response includes drug disposition (pharmacokinetics) and drug effect (pharmacodynamics).
PGt is applicable to activities such as drug discovery, drug development and clinical practise.
Currently, there are more than 200 drugs whose labelling includes pharmacogenetic information.
‘Test required’ examples: Cetuximab, Trastuzumab, Maraviroc, Abacavir, Dasatinib, Glivec, Tasigna, Gefitinib and Herceptin; ‘Test recommended’ examples: Carbamazepine, warfarin, azathioprine, etc.
In the coming years, evaluation by regulatory authorities of new medicines may involve increasingly PGt components in pre‐ and post‐approval development, and may therefore depend on reliable PGt information.
PGt is a rapidly and continuously evolving field; therefore, PGt studies should reflect on the ‘principles’ or necessary qualities of developing well‐controlled, rigorous and reproducible sample handling and testing procedures.
Key Concepts: Pharmacogenetics define populations that can have most benefit from a drug.
Pharmacogenetics improve drug development.
Pharmacogenetics predict disease course (to justify more intense or prolonged treatments) (diagnostics and prognostics).
Pharmacogenetics can be used to monitor the effects of the therapy (pharmacodynamics).
Genomic biomarkers predict clinical outcomes (surrogate endpoints).
Pharmacogenetics can be useful to identify new biological pathways involved in drug metabolism and therefore new treatment opportunities.
Pharmacogenetics is applicable to activities such as drug discovery, drug development and clinical practise.
Pharmacogenetics is applicable also in drug disposition (PK) and drug effect (PD).
Pharmacogenetics is necessary to define individual dose adaptation of chemotherapeutics and in general for personalised medicine.
Pharmacogenetics is crucial in genomic biomarkers identification.

Related Results

Pharmacogenetics and Theratyping in Pulmonology: A Practical Guide
Pharmacogenetics and Theratyping in Pulmonology: A Practical Guide
Background: Pulmonary diseases are a leading cause of global morbidity and mortality. Heterogeneity in drug response significantly limits treatment success. Pharmacogenetics and ge...
The Diffusion of Innovation: Factors Influencing the Uptake of Pharmacogenetics
The Diffusion of Innovation: Factors Influencing the Uptake of Pharmacogenetics
<i>Background:</i> Inspired by diffusion research, this paper examines how perceived need, health status, experiences with medicine and testing, consumption of mass med...
Ivan Illich, Iatrogenesis and Pharmacogenetics
Ivan Illich, Iatrogenesis and Pharmacogenetics
In Medical Nemesis - The expropriation of health, IVAN ILLICH highlights several aspects of the medicalization of society, which was already observed in the mid-1970s. He addressed...
Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues
Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues
Pharmacogenetics is the study of inherited variation in drug response. The goal of pharmacogenetics is to develop novel ways of maximizing drug efficacy and minimizing toxicity for...
Breast cancer: Role of pharmacogenetics in tamoxifen therapy
Breast cancer: Role of pharmacogenetics in tamoxifen therapy
<p><span>The role of pharmacogenetics in the personalization of tamoxifen therapy has relevance in the management of breast cancer. Since Tamoxifen is a pro-drug, genet...
Pharmacogenetics and Pharmacogenomics
Pharmacogenetics and Pharmacogenomics
This chapter traces the development of the science of pharmacogenetics and the clinical importance of polymorphisms of certain metabolic enzymes. It also examines the potential and...
Using Pharmacogenetics Knowledge to Increase Accuracy of Alerts for Adverse Drug Events
Using Pharmacogenetics Knowledge to Increase Accuracy of Alerts for Adverse Drug Events
Adverse drug event (ADE) has significant implications on patient safety and is recognized as a major cause of fatalities and hospital expenses. Although some medical systems today ...

Back to Top